Omada Health, Inc. (NASDAQ:OMDA) Stock Has Consensus Price Target of $26.67

Key Points

• Analysts maintain a moderately bullish outlook: Fourteen analysts give Omada Health a consensus “Moderate Buy” rating, with 11 buys, two holds and one sell. The average 12-month price target is $26.67, while recent targets from JPMorgan and Citizens Jmp reached $30 and $32, respectively.
• Omada exceeded quarterly expectations: The company reported earnings of $0.08 per share versus the expected $0.02 loss, while revenue of $87.83 million topped estimates of $80.93 million.
• Insiders have recently reduced their holdings: CEO Sean Duffy and CFO Steven Cook each sold shares, contributing to insider sales totaling 193,245 shares worth approximately $4.41 million in the last quarter.

Shares of Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) have been given a consensus rating of "Moderate Buy" by the fourteen analysts that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and eleven have issued a buy recommendation on the company. The average 1-year price target among brokerages that have covered the stock in the last year is $26.67.

A number of analysts recently weighed in on the stock. Wall Street Zen raised shares of Omada Health from a "hold" rating to a "buy" rating in a report on Saturday, August 8th. Morgan Stanley reissued an "overweight" rating and set a $30.00 target price on shares of Omada Health in a research note on Monday, June 22nd. JPMorgan Chase & Co. upped their target price on shares of Omada Health from $26.00 to $30.00 and gave the stock an "overweight" rating in a research report on Friday, August 14th. Citizens Jmp raised their price target on shares of Omada Health from $27.00 to $32.00 and gave the company a "market outperform" rating in a research note on Friday, August 14th. Finally, Weiss Ratings raised Omada Health from a "sell (e+)" rating to a "sell (d+)" rating in a report on Tuesday, August 11th.

Omada Health Price Performance

NASDAQ:OMDA opened at $19.72 on Friday. The firm has a market capitalization of $1.21 billion, a P/E ratio of 394.40 and a beta of 1.86. The business has a 50 day simple moving average of $22.08 and a 200 day simple moving average of $18.44. Omada Health has a 12-month low of $10.28 and a 12-month high of $26.92.

Omada Health (NASDAQ:OMDA - Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $0.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.02) by $0.10. Omada Health had a return on equity of 2.60% and a net margin of 1.39%.The company had revenue of $87.83 million for the quarter, compared to analysts' expectations of $80.93 million. Research analysts anticipate that Omada Health will post 0.09 EPS for the current fiscal year.

Insiders Place Their Bets

In other Omada Health news, CEO Sean Duffy sold 14,960 shares of Omada Health stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $21.87, for a total transaction of $327,175.20. Following the sale, the chief executive officer owned 382,594 shares of the company's stock, valued at $8,367,330.78. The trade was a 3.76% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Steven Cook sold 6,800 shares of the business's stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $21.86, for a total value of $148,648.00. Following the transaction, the chief financial officer owned 173,906 shares of the company's stock, valued at $3,801,585.16. This trade represents a 3.76% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 193,245 shares of company stock valued at $4,411,838 in the last quarter. 6.38% of the stock is owned by insiders.

Hedge Funds Weigh In On Omada Health

Several large investors have recently bought and sold shares of the stock. BlackRock Inc. acquired a new stake in shares of Omada Health in the 2nd quarter worth approximately $48,775,000. BIT Capital GmbH raised its holdings in Omada Health by 52.4% during the fourth quarter. BIT Capital GmbH now owns 940,238 shares of the company's stock worth $14,837,000 after purchasing an additional 323,365 shares in the last quarter. SG Americas Securities LLC acquired a new stake in Omada Health in the first quarter worth approximately $10,401,000. Jefferies Financial Group Inc. bought a new position in Omada Health during the 2nd quarter valued at $15,016,000. Finally, Madryn Asset Management LP acquired a new position in shares of Omada Health during the 4th quarter valued at $9,212,000.

About Omada Health

Omada Health, Inc is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines clinical care, health coaching, connected devices, digital tools and personalized support to help members improve health outcomes and manage conditions over time.

The company's offerings address areas including diabetes, hypertension, weight health and musculoskeletal conditions. Omada's programs are designed to support prevention and ongoing care through services such as remote monitoring, personalized health guidance, educational content and access to healthcare professionals.

Omada primarily serves members through employers, health plans and healthcare organizations in the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.